illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Cue Health
Company logo

Cue Health | Sustainability Performance

https://cuehealth.com/

Develops diagnostic testing platforms offering real-time health monitoring and at-home test solutions.

2010

United States

501 - 1,000 employees

Biotechnology

$25M - 100M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#11473
Overall
#2579
in United States
#227
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

133 out of 245

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Arcturus Therapeutics

United States, Health Care, Biotechnology


Company logo
Pivot Bio

United States, Health Care, Biotechnology


Company logo
Cumberland Pharmaceuticals

United States, Health Care, Pharmaceuticals

Market cap

0.0 $, 2026

Revenue

70.0M $, 2023▲590% YoY

R&D intensity

214.29% 2023

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

0.0 $, 2026▼NaN% YoY

Revenue

70.0M $, FY2023▲590% YoY

EBITDA

-296.0M $, FY2023▼9.1% YoY

Operating margin

-418% Industry: -8722▼89.9% YoY

Revenue & EBITDA

$70.0MFY2023 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-157.6M 2023▲11% YoY

Capex

19.0M 2023▲231.6% YoY

Debt/equity ratio

0.0 Industry: 2▼NaN% YoY

R&D intensity

214.3%FY2023

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-149.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.6

▼ 2.6%

2021

0.5

▲ 21.8%

2022

0.1

▼ 2.7%

2023

0.2

2026

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

63%
Independent Directors

5 out of 8 incl. management

Powered by illuminem

Overall score

35

Environment

15

Social

42

Governance

47

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


Total sustainability employees

1


    Available in
    Scale package

    Access
  • Email

  • Email